The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer.

by Mark Bates, Cathy D Spillane, Michael F Gallagher, Amanda McCann, Cara Martin, Gordon Blackshields, Helen Keegan, Luke Gubbins, Robert Brooks, Doug Brooks, Stavros Selemidis, Sharon O'Toole, John J O'Leary
Published 2020-01-01

The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon

by Cathy D. Spillane, Niamh M. Cooke, Mark P. Ward, Dermot Kenny, Gordon Blackshields, Tanya Kelly, Mark Bates, Yanmei Huang, Cara Martin, Sinead Skehan, Aoife Canney, Michael Gallagher, Paul Smyth, Nathan Brady, Andres Clarke, Bashir Mohamed, Lucy Norris, Doug A. Brooks, Robert D. Brooks, Jessica K. Heatlie, Stavros Selemidis, Sean Hanniffy, Eric Dixon, Orla Sheils, Sharon A. O'Toole, John J. O'Leary
Published 2021-12-01

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

by Charles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, Mark Bates, Katie M Costello, Jacqui Barry-O'Crowley, Kathryn Haley, Niamh Kernan, Ciara Murphy, Paul C Smyth, Ken O'Byrne, Stephen Pennington, Aoife A Cooke, Brendan Ffrench, Cara M Martin, Dearbhaile O'Donnell, Bryan Hennessy, Britta Stordal, Stephen Finn, Amanda McCann, Noreen Gleeson, Tom D'Arcy, Brian Flood, Luke A J O'Neill, Orla Sheils, Sharon O'Toole, John J O'Leary
Published 2014-01-01